CTMX - Financial Reports List - CytomX Therapeutics, Inc. - IntrinsicAlpha

CytomX Therapeutics, Inc. CTMX

Healthcare - Biotechnology - NASDAQ - US

$ 2.195

-0.971 %

$ 346 M

Market Cap

4.25

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-03-31	22.80%	70.58%	94.06%
Quarterly Report	Q4	8-K	2024-12-31	43.17%	2155.20%	3017.33%
Annual Report	FY	10-K	2024-12-31	36.45%	5700.88%	485.49%
Quarterly Report	Q3	8-K	2024-09-30	26.71%	91.71%	31.64%
Quarterly Report	Q2	8-K	2024-06-30	1.58%	-501.10%	-152.45%
Quarterly Report	Q1	8-K	2024-03-31	76.45%	1523.22%	306.21%
Quarterly Report	Q4	8-K	2023-12-31	2712.58%	103.15%	97.89%
Annual Report	FY	10-K	2023-12-31	90.38%	99.42%	93.60%
Quarterly Report	Q3	8-K	2023-09-30	55.98%	113.21%	113.04%
Quarterly Report	Q2	8-K	2023-06-30	36.11%	95.40%	86.47%

1